JP2004532828A5 - - Google Patents

Download PDF

Info

Publication number
JP2004532828A5
JP2004532828A5 JP2002572952A JP2002572952A JP2004532828A5 JP 2004532828 A5 JP2004532828 A5 JP 2004532828A5 JP 2002572952 A JP2002572952 A JP 2002572952A JP 2002572952 A JP2002572952 A JP 2002572952A JP 2004532828 A5 JP2004532828 A5 JP 2004532828A5
Authority
JP
Japan
Prior art keywords
tramadol
pharmaceutical composition
milligrams
cis
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002572952A
Other languages
English (en)
Japanese (ja)
Other versions
JP4377585B2 (ja
JP2004532828A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/007928 external-priority patent/WO2002074241A2/en
Publication of JP2004532828A publication Critical patent/JP2004532828A/ja
Publication of JP2004532828A5 publication Critical patent/JP2004532828A5/ja
Application granted granted Critical
Publication of JP4377585B2 publication Critical patent/JP4377585B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

JP2002572952A 2001-03-16 2002-03-15 射精遅延の方法 Expired - Fee Related JP4377585B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27680601P 2001-03-16 2001-03-16
PCT/US2002/007928 WO2002074241A2 (en) 2001-03-16 2002-03-15 Method of delaying ejaculation

Publications (3)

Publication Number Publication Date
JP2004532828A JP2004532828A (ja) 2004-10-28
JP2004532828A5 true JP2004532828A5 (cg-RX-API-DMAC10.html) 2006-01-05
JP4377585B2 JP4377585B2 (ja) 2009-12-02

Family

ID=23058139

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002572952A Expired - Fee Related JP4377585B2 (ja) 2001-03-16 2002-03-15 射精遅延の方法

Country Status (17)

Country Link
US (2) US6974839B2 (cg-RX-API-DMAC10.html)
EP (1) EP1397126B9 (cg-RX-API-DMAC10.html)
JP (1) JP4377585B2 (cg-RX-API-DMAC10.html)
KR (1) KR100908350B1 (cg-RX-API-DMAC10.html)
CN (1) CN1289071C (cg-RX-API-DMAC10.html)
AT (1) ATE326957T1 (cg-RX-API-DMAC10.html)
AU (1) AU2002252361C1 (cg-RX-API-DMAC10.html)
CA (2) CA2758923A1 (cg-RX-API-DMAC10.html)
CY (1) CY1107478T1 (cg-RX-API-DMAC10.html)
DE (1) DE60211689T2 (cg-RX-API-DMAC10.html)
DK (1) DK1397126T5 (cg-RX-API-DMAC10.html)
ES (1) ES2265495T3 (cg-RX-API-DMAC10.html)
MX (1) MXPA03008372A (cg-RX-API-DMAC10.html)
NZ (1) NZ528935A (cg-RX-API-DMAC10.html)
PT (1) PT1397126E (cg-RX-API-DMAC10.html)
WO (1) WO2002074241A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200308067B (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ528935A (en) * 2001-03-16 2004-10-29 Dmi Biosciences Inc Method of delaying ejaculation
US8575169B2 (en) 2001-10-29 2013-11-05 Versi Group, Llc Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
US7754767B2 (en) * 2002-11-06 2010-07-13 Trinity Laboratories, Inc. Method for treatment of premature ejaculation in humans
WO2004078143A2 (en) * 2003-03-05 2004-09-16 The Brigham And Women's Hospital Inc. Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs
AU2004224329B2 (en) 2003-03-21 2009-07-09 Nexmed (Holdings), Inc. Compositions and methods for treatment of premature ejaculation
AU2003903597A0 (en) * 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
US8604082B2 (en) * 2005-12-13 2013-12-10 Trinity Laboratories, Inc. Method to treat premature ejaculation in humans
FR2907121B1 (fr) 2006-10-12 2012-05-04 Neorphys Nouveaux derives morphiniques
ES2384481T3 (es) * 2007-02-12 2012-07-05 Dmi Biosciences, Inc. Tratamiento de la eyaculación precoz y la disfunción eréctil co-morbidas
ES2384127T3 (es) 2007-02-12 2012-06-29 Dmi Biosciences, Inc. Reducción de los efectos secundarios del tramadol
WO2008131256A1 (en) * 2007-04-19 2008-10-30 Trinity Laboratories Inc. Improved treatments for premature ejaculation in humans
US20090005319A1 (en) * 2007-07-01 2009-01-01 Barone Jr Frank V Topical compositions for delaying ejaculation and methods of using the same
KR101103118B1 (ko) * 2007-11-02 2012-01-04 동아제약주식회사 신규한 1,3-디히드로-5-이소벤조퓨란카르보니트릴 유도체 화합물 및 이를 함유하는 조루증 치료용 약학조성물
US8147848B2 (en) 2009-08-26 2012-04-03 Allergan, Inc. Method for treating premature ejaculation with a botulinum neurotoxin
GR1007315B (el) * 2010-04-19 2011-06-14 Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Abee, Υγρομορφη παρεντερικης χορηγησης συνθεση που περιλαμβανει τραμαδολη hci και παρακεταμολη
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol
US20180071269A1 (en) 2015-08-12 2018-03-15 Tianxin Wang Therapeutical methods, formulations and nutraceutical formulations
US11000488B2 (en) 2019-03-22 2021-05-11 Syntrix Biosystems Inc. Treating pain using desmetramadol

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
US3830934A (en) 1967-07-27 1974-08-20 Gruenenthal Chemie Analgesic and antitussive compositions and methods
US4507323A (en) 1984-07-25 1985-03-26 Burroughs Wellcome Co. Treatment of psychosexual dysfunctions
US4940731A (en) 1989-08-30 1990-07-10 Pfizer Inc. Method of treating premature ejaculation using sertraline
US5151448A (en) 1991-07-12 1992-09-29 Crenshaw Roger T Method for treating premature ejaculation
DK0566709T5 (da) 1991-09-06 2009-05-18 Ortho Mcneil Janssen Pharm Præparat indeholdende et tramadolmateriale og acetaminophen og anvendelse deraf
HU217584B (hu) 1991-09-06 2000-02-28 Mcneilab Inc. Egy tramadolszármazékot és kodeint, oxikodont vagy hidrokodont tartalmazó szinergetikus gyógyászati készítmények, és eljárás előállításukra
US5223541A (en) 1991-09-13 1993-06-29 Mcneilab, Inc. Tramadol n-oxide material, enantiomers and compositions thereof, and their use
US5516803A (en) * 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5276042A (en) 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
IL119660A (en) 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
DE4329794C2 (de) 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
IT1264965B1 (it) 1993-11-12 1996-10-17 Giorgio Cavallini Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
US6017963A (en) 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
DE19547766A1 (de) 1995-12-20 1997-06-26 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe
DE19601744C2 (de) 1996-01-19 1998-04-16 Gruenenthal Gmbh Verfahren zur Herstellung der Enantiomeren von O-Demethyltramadol
DE19601745C1 (de) 1996-01-19 1997-10-09 Gruenenthal Gmbh Verfahren zur Racematspaltung von Tramadol
DE19609847A1 (de) 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
IL119121A (en) 1996-08-22 2000-11-21 Chemagis Ltd Process for the purification of (RR-SS)-2-dimethylaminomethyl-1-(3-methoxyphenyl)cyclohexanol hydrochloride
DE19641576C1 (de) 1996-10-09 1998-05-07 Gruenenthal Gmbh Kombinationspräparat enthaltend Tramadol und einen Calcium-Kanal Antagonisten
US5919826A (en) 1996-10-24 1999-07-06 Algos Pharmaceutical Corporation Method of alleviating pain
AU6747698A (en) 1997-04-11 1998-11-11 Nippon Shinyaku Co. Ltd. Remedies for frequent urination and urinary incontinence
US6399618B1 (en) 1997-07-09 2002-06-04 Cardiome Pharma Corp Compositions and methods for modulating sexual activity
US5922341A (en) 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6228864B1 (en) 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
US6037360A (en) 1997-10-28 2000-03-14 Vivus, Incorporated Administration of 5-HT3 receptor antagonists to treat premature ejaculation
US6156342A (en) 1998-05-26 2000-12-05 Andex Pharmaceuticals, Inc. Controlled release oral dosage form
GB2340037A (en) 1998-07-30 2000-02-16 Glaxo Group Ltd Compositions comprising bupropion for the treatment of premature ejaculation
US6337328B1 (en) 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
WO2000056309A1 (en) 1999-03-19 2000-09-28 Knoll Pharmaceutical Company Method of treating sexual dysfunction
EP1180021A4 (en) 1999-05-06 2005-01-19 Pentech Pharmaceuticals Inc TREATMENT OF THE PREMATURE EJACULATION AND ASSOCIATED KIT
DK1225881T3 (da) 1999-09-03 2006-06-12 Apbi Holdings Llc Anvendelsen af dapoxetin, en hurtigt-virkende selektiv serotonin genoptagelseshæmmer, til behandling af seksuel dysfunktion
US6339105B1 (en) 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
US6297286B1 (en) 1999-11-09 2001-10-02 Darwin Discovery, Ltd. Therapeutic use and formulation
US6630138B2 (en) 2000-02-11 2003-10-07 Eli Lilly And Company Protein C derivatives
US6369051B1 (en) 2000-07-06 2002-04-09 American Home Products Corporation Combinations of SSRI and estrogenic agents
US6495154B1 (en) 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
NZ528935A (en) * 2001-03-16 2004-10-29 Dmi Biosciences Inc Method of delaying ejaculation

Similar Documents

Publication Publication Date Title
JP2004532828A5 (cg-RX-API-DMAC10.html)
CN1878757A (zh) 吡啶酮衍生物及其应用
EP2298416A3 (en) Sustained-release tramadol formulations with 24-hour clinical efficacy
JP2006526031A5 (cg-RX-API-DMAC10.html)
JP2006526590A5 (cg-RX-API-DMAC10.html)
JP2007514005A5 (cg-RX-API-DMAC10.html)
CA2429844A1 (en) Mch antagonists and their use in the treatment of obesity
JP2006502187A5 (cg-RX-API-DMAC10.html)
HUP0401714A2 (hu) Propiverin vagy gyógyászatilag elfogadható sóinak nyújtott hatóanyag-eladású, orális adagolási formái
JP2003531118A5 (cg-RX-API-DMAC10.html)
WO2003005968A3 (en) Dual release levodopa ethyl ester and decarboxylase inhibitor with immediate release levodopa
JP2005504782A5 (cg-RX-API-DMAC10.html)
CA2476201A1 (en) Modified release formulations of at least one form of tramadol
CA2301378A1 (en) Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
JP2004500426A5 (cg-RX-API-DMAC10.html)
JP2011527333A5 (cg-RX-API-DMAC10.html)
JP2005509503A5 (cg-RX-API-DMAC10.html)
JP2008516004A5 (cg-RX-API-DMAC10.html)
WO2003005967A3 (en) Dual release levodopa ethyl ester and decarboxylase in controlled release core
JP2008513510A5 (cg-RX-API-DMAC10.html)
JP2009517411A5 (cg-RX-API-DMAC10.html)
WO2005004915A3 (en) Compositions comprising meloxicam
JP2010500284A5 (cg-RX-API-DMAC10.html)
EP2020233A3 (en) Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
CA2589744A1 (en) Pyrrolinidium derivatives as m3 muscarinic receptors